On October 3, 2022, Robert King, Ph.D., Chief Development Officer of Alector, Inc., notified the Company of his decision to resign from his position, effective October 28, 2022, to pursue another professional opportunity.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.03 USD | +2.24% | +0.80% | -36.97% |
14/05 | Transcript : Alector, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:55 AM | |
08/05 | Alector, Inc. Reiterates Revenue Guidance for the Year Ending 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.97% | 485M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.37% | 22.48B | |
-9.56% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- ALEC Stock
- News Alector, Inc.
- Alector, Inc. Announces Resignation of Robert King as Chief Development Officer